Literature DB >> 10617708

Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease.

D R Ehlenfield1, K Cameron, R C Welliver.   

Abstract

OBJECTIVE: Bronchiolitis in infancy is viewed as a risk factor for childhood asthma, but factors predicting which infants will have persistent wheezing have not been identified. In addition, the nature of the association between the 2 conditions is uncertain. We wished to determine whether eosinophil counts at the time of acute bronchiolitis predicted the presence of wheezing in later childhood.
METHODS: We retrospectively identified infants hospitalized with bronchiolitis, determined peripheral blood eosinophil counts at the time of bronchiolitis, and then contacted their families when they had reached 7 years of age.
RESULTS: Eosinophil counts at the time of bronchiolitis were greater in subjects who would have wheezing at 7 years of age (median: 98 cells/mm(3)) than in infants who would have no recurrent wheezing (median: 0 cells/mm(3)) or transient wheezing only up to 3 years of age (median: 0 cells/mm(3)). When the effects of family history of asthma, gender, and passive exposure to cigarette smoke were examined, only eosinophilia at the time of bronchiolitis demonstrated a statistically significant relationship to the presence of wheezing at 7 years of age.
CONCLUSIONS: Eosinophilia at the time of bronchiolitis generally predicts the development of wheezing persisting into later childhood. Therefore, the association of bronchiolitis and childhood asthma seems more likely to be attributable to an immunologic anomaly that precedes the development of, or is induced by, bronchiolitis rather than to structural damage to the airway as a result of bronchiolitis.

Entities:  

Mesh:

Year:  2000        PMID: 10617708     DOI: 10.1542/peds.105.1.79

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  26 in total

1.  Environmental factors association between asthma and acute bronchiolitis in young children--a perspective cohort study.

Authors:  Hui-Wen Lin; Sheng-Chieh Lin
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

2.  Exhaled Nitric Oxide in Acute Phase of Bronchiolitis and Its Relation with Episodes of Subsequent Wheezing in Children of Preschool Age.

Authors:  Jose Antonio Peña Zarza; Borja Osona; Jose Antonio Gil-Sanchez; Joan Figuerola
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2012-06       Impact factor: 1.349

3.  Factors Associated With Asthma Diagnosis Within Five Years of a Bronchiolitis Hospitalization: A Retrospective Cohort Study in a High Asthma Prevalence Population.

Authors:  Amanda J Clark; Nancy Dong; Talia Roth; Lindsey C Douglas
Journal:  Hosp Pediatr       Date:  2019-10

4.  Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in seoul, Korea, 2003-2008.

Authors:  Chang Keun Kim; Jungi Choi; Zak Callaway; Hyo Bin Kim; Ju Young Chung; Young-Yull Koh; Bo Moon Shin
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

Review 5.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  Primary murine airway smooth muscle cells exposed to poly(I,C) or tunicamycin synthesize a leukocyte-adhesive hyaluronan matrix.

Authors:  Mark E Lauer; Durba Mukhopadhyay; Csaba Fulop; Carol A de la Motte; Alana K Majors; Vincent C Hascall
Journal:  J Biol Chem       Date:  2008-12-16       Impact factor: 5.157

7.  Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.

Authors:  Teresa R Johnson; Marc E Rothenberg; Barney S Graham
Journal:  J Leukoc Biol       Date:  2008-06-02       Impact factor: 4.962

Review 8.  Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field.

Authors:  Prasad S Kulkarni; Julia L Hurwitz; Eric A F Simões; Pedro A Piedra
Journal:  Viral Immunol       Date:  2018-01-16       Impact factor: 2.257

Review 9.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

10.  Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.

Authors:  Grada M van Bleek; Martien C Poelen; Robbert van der Most; Humphrey F Brugghe; Hans A M Timmermans; Claire J Boog; Peter Hoogerhout; Henny G Otten; Cécile A C M van Els
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.